Drugs Made In America Acquisition (DMIIR) Shares Outstanding (2024 - 2025)

Drugs Made In America Acquisition (DMIIR) has 2 years of Shares Outstanding data on file, last reported at $13.7 million in Q4 2025.

• Quarterly Shares Outstanding fell 4.7% year-over-year to $13.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $13.7 million (down 4.7% YoY) and the FY2025 annual result came in at $13.7 million, down 4.7% from the prior year.
• Shares Outstanding fell to $13.7 million in Q4 2025 per DMIIR's latest filing, from $15.6 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $15.6 million in Q3 2025 and bottomed at $13.7 million in Q4 2025.

Peer Comparison